The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
about
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantationRNA vaccines in cancer treatmentBiogenesis of Leishmania major-harboring vacuoles in murine dendritic cellsEvaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemiaAntibody Targeting of "Steady-State" Dendritic Cells Induces Tolerance Mediated by Regulatory T CellsImmunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsThe Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseLeishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral LeishmaniasisPulmonary dendritic cell development and antigen acquisitionFluorogenic probes for monitoring peptide binding to class II MHC proteins in living cellsDendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c miceDendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivoDC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo.Monocyte-derived dendritic cells exhibit increased levels of lysosomal proteolysis as compared to other human dendritic cell populations.Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.In vivo maturation and migration of dendritic cells.FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapyDendritic cells inhibit the progression of Listeria monocytogenes intracellular infection by retaining bacteria in major histocompatibility complex class II-rich phagosomes and by limiting cytosolic growthIncorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV.Dendritic cell regulation of TH1-TH2 development.Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae.Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo.Mature T cell seeks antigen for meaningful relationship in lymph node.Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?Killing of dendritic cells: a life cut short or a purposeful death?Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells.Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levelsModulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.Some interfaces of dendritic cell biology.Targeting dendritic cells for priming cellular immune responses.Translating cell biology in vitro to immunity in vivo.Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiationEntry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factorsDual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.Autonomous phagosomal degradation and antigen presentation in dendritic cells.Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery.
P2860
Q21284774-62C4C9A2-B356-482B-B0DA-2A01057190DBQ21296852-E6E9EBD0-B726-42DC-A82A-49FFED6785D2Q24537365-0BF91B6D-CE25-42F5-929C-283F32114B92Q24800882-DF76D9BA-7686-45EA-8F3D-7ED684E82796Q26768528-399BEE29-C93D-4783-9C07-ED1281E6FE32Q26777195-A5377A94-8601-4517-8EA6-628522A1B810Q26784452-63706ACC-92A0-4677-9836-8CA6B0C2D909Q26858852-2E05CAC4-E3FB-4EC0-B212-853ADB3DFCC2Q26864537-98F38217-81A2-4B00-9A58-9FD2FC86DFFBQ27644030-C1DC075D-1462-4ECE-B2C3-8DBF7146FC78Q28480976-51B975CD-F975-40EB-8C8A-D2BA02082E9CQ30080006-F11FDE25-C15B-402A-B87A-D81C556B023FQ33627385-98FD62AB-AEAC-45FC-92B7-3B846B0B84A5Q33651251-A852EC36-B178-4145-B546-068234FB25EAQ33897693-A14FBD97-020A-48BF-9119-ABB2C0A15063Q33902421-163118E5-38BC-4F14-87F6-2F1151EEFA3DQ33942185-7FF5CDF6-B09E-4021-ABE0-4A76D9A322BBQ33951651-D8C6B1F3-9B79-4AE5-8979-8A79BD5F1F57Q33963180-5C77D302-587A-424F-B2AB-8395C94C12E9Q34005446-0C86017B-FF3B-4EFE-8575-CAEDF2816FF5Q34023428-A46C6F65-6145-49E1-A747-554BB846B3C6Q34118627-A7D00BCE-1A6C-49CF-BF78-12872B744D72Q34167920-DA7568C7-6BAE-4188-84A7-36CF02A0FD73Q34214364-1F11A105-AC71-4E03-B3AB-91A767AB9FB1Q34235880-CF0B8FE8-3652-46F7-AAF7-8100D292CC6AQ34338355-7A957D68-BE17-403A-8D1B-BA2156E407E8Q34355697-A235BE8D-0108-4426-A72E-F9718444C810Q34377531-D013ACBA-C959-4810-AD0D-EB2422909BA2Q34913590-DAE855CE-1E92-4A4A-8911-90E102C95AEAQ35205220-CAF9AB7A-8E4C-4D16-8EEC-9977B11A4653Q35219290-0A1E0DD0-4D0B-4BA6-BA29-00FB24D5D660Q35549421-F8FBEC8B-C07A-4B2B-9388-479FD149A956Q35829758-4C014231-761A-4352-BF06-77BFBF57C006Q35848573-D0340147-0521-4DE8-A454-E560F8F305CAQ35852370-ED4229FB-4CB4-4CB1-9EF4-D1F3E02D1B73Q35928330-774FEB61-E5BA-4AB5-A7CA-EC0C22A807D9Q35951845-06CDA149-2B10-4D75-840A-8CEB1AF8DCEEQ36178572-69DA741F-A94D-4562-9195-D49EE15F9742Q36221894-DBF163A5-61C1-4027-A4C4-97CFA3A7B114Q36228368-FBEFE343-F676-4846-9CC8-8CF375B21707
P2860
The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The formation of immunogenic m ...... lated by inflammatory stimuli.
@ast
The formation of immunogenic m ...... lated by inflammatory stimuli.
@en
type
label
The formation of immunogenic m ...... lated by inflammatory stimuli.
@ast
The formation of immunogenic m ...... lated by inflammatory stimuli.
@en
prefLabel
The formation of immunogenic m ...... lated by inflammatory stimuli.
@ast
The formation of immunogenic m ...... lated by inflammatory stimuli.
@en
P2093
P2860
P356
P1476
The formation of immunogenic m ...... lated by inflammatory stimuli.
@en
P2093
C Reis e Sousa
R M Steinman
R N Germain
S Shimoyama
P2860
P304
P356
10.1084/JEM.191.6.927
P407
P577
2000-03-01T00:00:00Z